DEVON ELDER: Open Payments
NPI 1962136044 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 21 payments from 14 companies in 2025. Trend: 2023 $3,352 · 2024 $2,097 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Amgen Inc. | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| UCB, Inc. | 2 | $41 |
| GENZYME CORPORATION | 1 | $27 |
| LEO Pharma Inc. | 1 | $26 |
| Incyte Corporation | 1 | $24 |
| Cipher Pharmaceuticals US LLC | 1 | $20 |
| LNHC, Inc | 1 | $20 |
| Biofrontera Inc. | 1 | $19 |
Products named: COSENTYX, OTEZLA, Bimzelx, DUPIXENT, AYVAKIT, ADBRY, OPZELURA, Natroba.
Industry payments across TX — which companies pay providers there.
